UMIN ID: UMIN000001392
Registered date:26/09/2008
A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Non-small cell lung cancer |
| Date of first enrollment | 2006/01/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Vinorelbine+ Thoracic radiotherapy |
Outcome(s)
| Primary Outcome | To determine recommended dose |
|---|---|
| Secondary Outcome | Safety, Response rate, 2-year survival rate, progression free suevival. |
Key inclusion & exclusion criteria
| Age minimum | 71years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Interstitial pneumonia. No eligibility for definitive radiotherapy. |
Related Information
| Primary Sponsor | West Japan Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shinichiro Nakamura |
| Address | Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan |
| Telephone | 06-6633-7400 |
| datacenter@wjog.jp | |
| Affiliation | West Japan Oncology Group WJOG datacenter |
| scientific contact | |
| Name | Hideyuki Harada |
| Address | Shimonagakubo 1007, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan Japan |
| Telephone | 055-989-5222 |
| Affiliation | Shizuoka Cancer Center Radiation Oncology |